These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 23008313)
1. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313 [TBL] [Abstract][Full Text] [Related]
2. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003 [TBL] [Abstract][Full Text] [Related]
3. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS). Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221 [TBL] [Abstract][Full Text] [Related]
4. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945 [TBL] [Abstract][Full Text] [Related]
5. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS). Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981 [TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Khorana AA; Dalal M; Lin J; Connolly GC Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596 [TBL] [Abstract][Full Text] [Related]
7. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study. Lötsch F; Königsbrügge O; Posch F; Zielinski C; Pabinger I; Ay C Thromb Res; 2014 Nov; 134(5):1008-13. PubMed ID: 25234407 [TBL] [Abstract][Full Text] [Related]
8. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J; J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180 [TBL] [Abstract][Full Text] [Related]
9. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients. Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Khorana AA; Francis CW; Culakova E; Lyman GH Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987 [TBL] [Abstract][Full Text] [Related]
11. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis. Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients. Thaler J; Preusser M; Ay C; Kaider A; Marosi C; Zielinski C; Pabinger I; Hainfellner JA Thromb Res; 2013 Feb; 131(2):162-5. PubMed ID: 23084660 [TBL] [Abstract][Full Text] [Related]
13. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study. Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I; Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897 [TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients. Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799 [TBL] [Abstract][Full Text] [Related]
15. Postoperative venous thromboembolism predicts survival in cancer patients. Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195 [TBL] [Abstract][Full Text] [Related]
16. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780 [TBL] [Abstract][Full Text] [Related]
17. Rates of venous thromboembolism occurrence in medical patients among the insured population. Spyropoulos AC; Hussein M; Lin J; Battleman D Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534 [TBL] [Abstract][Full Text] [Related]